Mindfulness for at Risk Youth: Understanding Substance Use and Important Mechanisms of Change
1 other identifier
interventional
24
1 country
1
Brief Summary
This study will be the first to explore mindfulness as a prevention intervention among transition age youth and those with previous involvement in the juvenile or criminal justice system with substance use problems and history of exposure to violence/trauma. The study will focus on preventing escalation of substance use (e.g., alcohol and marijuana), trauma symptoms, and recidivism by using an intervention to target self-regulation and executive functioning. Justice involved youth have higher rates of alcohol use and related consequences and higher rates of exposure to violence (Post Traumatic Stress Disorder) compared to their non-justice involved peers. Prior research has found aspects of self-regulation (emotion regulation, impulse control), stress, and craving to be important putative targets in reducing alcohol use. With high rates of recidivism and increased risk of long term problems associated with substance use, it is imperative to test interventions that can reach at risk youth and target both alcohol use and important psychological and neurocognitive self-regulation mechanisms. This study tests whether the use of Mindfulness-Based Relapse Prevention (MBRP) for at risk young adults results in changes in important self-regulation mechanisms and improved alcohol use outcomes. Individuals assigned to the experimental group will receive interventions normally provided at a community clinic and eight 1.5-hour group sessions of MBRP. Sessions will occur once per week. Each session will target a specific theme such as being aware of personal triggers, maintaining present focus, allowing or letting things be, responding to emotional and physical experiences in skillful ways, and recognizing intrusive thoughts. Further, each session will incorporate a mindfulness meditation technique. The central hypothesis will be tested through a focus on three specific aims: (1) Beta pilot testing and refining MBRP based on feedback from focus groups, (2) testing the efficacy of MBRP on substance use outcomes compared to an active control, and (3) assessing mechanisms of change for MBRP including self-regulation and neurocognitive facets such as working memory and inhibition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 3, 2018
CompletedStudy Start
First participant enrolled
March 5, 2019
CompletedFirst Posted
Study publicly available on registry
November 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedSeptember 29, 2021
September 1, 2021
1.3 years
October 3, 2018
September 27, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Substance Use
Substance use will be measured using time line follow back approach for 15 different substances. We will ask about days of use and number of times used for each substance in the past month
Baseline, 1 month, 2 months, 3 months, 4 months, 5 months
Change in PTSD symptoms
Initial screening of PTSD symptoms will be assessed by the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5). We will further assess PTSD symptoms using the PTSD Checklist for DSM-5 (PCL-5). The PCL-5 is a 20-item self-report measure that assesses the 20 Diagnostic and Statistical Manual of Mental Disorders (DSM-5) symptoms of PTSD.
Baseline, 1 month, 2 months, 3 months, 4 months, 5 months
Change in Depression
Depression will be measured with the Center for Epidemiologic Studies Depression Scale (CES-D). The CES-D includes 20 items instructing participants how often they have experienced a variety of symptoms in the past week, ranging from "rarely or none of the time" to "Most or all of the time." The scoring of positive items is reversed. Possible range of scores is zero to 60, with the higher scores indicating the presence of more symptomology.
Baseline, 1 month, 2 months, 3 months, 4 months, 5 months
Secondary Outcomes (6)
Executive Functioning
Baseline, 2 months post-baseline
Emotion Regulation
Baseline, 1 month, 2 months, 3 months, 4 months, 5 months
Impulsivity
Baseline, 1 month, 2 months, 3 months, 4 months, 5 months
Delinquency
Baseline, 1 month, 2 months, 3 months, 4 months, 5 months
Stress
Baseline, 1 month, 2 months, 3 months, 4 months, 5 months
- +1 more secondary outcomes
Study Arms (2)
MBRP
EXPERIMENTALThe experimental group will receive treatment as usual plus eight Mindfulness based relapse prevention (MBRP) therapy sessions.
Control (CTL)
ACTIVE COMPARATORThe CTL group will receive treatment as usual plus information on the neurobiology of addiction and healthy behaviors.
Interventions
Individuals assigned to the experimental group will receive interventions normally provided at the clinic and eight 1.5-hour group sessions of MBRP. Each sessions will occur once per week and will target a specific theme such as being aware of personal triggers, maintaining present focus, allowing or letting things be, responding to emotional and physical experiences in skillful ways, and recognizing intrusive thoughts. Each session will incorporate a mindfulness meditation technique (e.g.,SOBER breathing space and "urge surfing"). Participants will receive materials (e.g., recordings) with which to perform practices and meditation during the intervention phase.
Individuals assigned to the CTL group will receive interventions provided at the clinic and up to eight CTL sessions. The CTL group will receive information (reading) and videos once per week on health behaviors (e.g., exercise, eating) and the neurobiology of addiction. This approach will reduce the possibility that intervention effects are solely due to the experimental group's receiving extra attention. In contrast to the active intervention, sessions will be educational in nature, with no motivational, cognitive, or behavioral components
Eligibility Criteria
You may qualify if:
- to 26 years old at baseline
- English speaking
- Be willing to provide follow-up information
- Report past-month use of alcohol or drugs
- Score 2 or higher on the PC-PTSD scale
- Not currently receiving substance abuse treatment elsewhere
- Not prisoners
You may not qualify if:
- Does not speak English
- Receiving treatment from some other facility for substance use.
- Active psychosis symptoms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Southern California, School of Social Work
Los Angeles, California, 90089, United States
Related Publications (14)
Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994 Apr-Jun;50(1-3):7-15. doi: 10.1016/0010-0277(94)90018-3.
PMID: 8039375BACKGROUNDCyders MA, Littlefield AK, Coffey S, Karyadi KA. Examination of a short English version of the UPPS-P Impulsive Behavior Scale. Addict Behav. 2014 Sep;39(9):1372-6. doi: 10.1016/j.addbeh.2014.02.013. Epub 2014 Mar 3.
PMID: 24636739BACKGROUNDDavis JP, Berry D, Dumas TM, Ritter E, Smith DC, Menard C, Roberts BW. Substance use outcomes for mindfulness based relapse prevention are partially mediated by reductions in stress: Results from a randomized trial. J Subst Abuse Treat. 2018 Aug;91:37-48. doi: 10.1016/j.jsat.2018.05.002. Epub 2018 May 20.
PMID: 29910013BACKGROUNDEspelage, D. L., & Holt, M. K. (2001). Bullying and victimization during early adolescence: Peer influences and psychosocial correlates. Journal of Emotional Abuse, 2(2-3), 123-142. https://doi.org/10.1300/J135v02n02_08
BACKGROUNDHallion LS, Steinman SA, Tolin DF, Diefenbach GJ. Psychometric Properties of the Difficulties in Emotion Regulation Scale (DERS) and Its Short Forms in Adults With Emotional Disorders. Front Psychol. 2018 Apr 19;9:539. doi: 10.3389/fpsyg.2018.00539. eCollection 2018.
PMID: 29725312BACKGROUNDHimelstein, S. (2011). Mindfulness-Based Substance Abuse Treatment for Incarcerated Youth: A Mixed Method Pilot Study. International Journal of Transpersonal Studies, 1-10.
BACKGROUNDHimelstein, Sam, Hastings, A., Shapiro, S., & Heery, M. (2012). Mindfulness training for self-regulation and stress with incarcerated youth. Probation Journal, 59(2), 151-165. https://doi.org/10.1177/0264550512438256
BACKGROUNDHimelstein S, Saul S, Garcia-Romeu A, Pinedo D. Mindfulness training as an intervention for substance user incarcerated adolescents: a pilot grounded theory study. Subst Use Misuse. 2014 Apr;49(5):560-70. doi: 10.3109/10826084.2013.852580.
PMID: 24611851BACKGROUNDJackson JD, Balota DA. Mind-wandering in younger and older adults: converging evidence from the Sustained Attention to Response Task and reading for comprehension. Psychol Aging. 2012 Mar;27(1):106-119. doi: 10.1037/a0023933. Epub 2011 Jun 27.
PMID: 21707183BACKGROUNDLeonard NR, Jha AP, Casarjian B, Goolsarran M, Garcia C, Cleland CM, Gwadz MV, Massey Z. Mindfulness training improves attentional task performance in incarcerated youth: a group randomized controlled intervention trial. Front Psychol. 2013 Nov 8;4:792. doi: 10.3389/fpsyg.2013.00792. eCollection 2013.
PMID: 24265621BACKGROUNDPrins A, Bovin MJ, Smolenski DJ, Marx BP, Kimerling R, Jenkins-Guarnieri MA, Kaloupek DG, Schnurr PP, Kaiser AP, Leyva YE, Tiet QQ. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): Development and Evaluation Within a Veteran Primary Care Sample. J Gen Intern Med. 2016 Oct;31(10):1206-11. doi: 10.1007/s11606-016-3703-5. Epub 2016 May 11.
PMID: 27170304BACKGROUNDSelner-O'Hagan MB, Kindlon DJ, Buka SL, Raudenbush SW, Earls FJ. Assessing exposure to violence in urban youth. J Child Psychol Psychiatry. 1998 Feb;39(2):215-24.
PMID: 9669234BACKGROUNDCohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
PMID: 6668417BACKGROUNDWeathers FW, Bovin MJ, Lee DJ, Sloan DM, Schnurr PP, Kaloupek DG, Keane TM, Marx BP. The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychol Assess. 2018 Mar;30(3):383-395. doi: 10.1037/pas0000486. Epub 2017 May 11.
PMID: 28493729BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 3, 2018
First Posted
November 13, 2019
Study Start
March 5, 2019
Primary Completion
June 30, 2020
Study Completion
June 30, 2020
Last Updated
September 29, 2021
Record last verified: 2021-09